Bilkul Online | Sunday SpecialNew DelhiA platform that lets researchers observe living cells on a continuous basis could transform drug discovery, reshape cancer research and precision medicine, according to experts on Saturday. Cancer drug development remains one of the most difficult areas of pharmaceutical research. Industry studies have consistently shown that the vast majority of oncology drug candidates entering clinical development ultimately fail before reaching patients. Scientists increasingly attribute many failures to the inability of existing laboratory models to fully capture the complexity and dynamic behaviour of living cells. India reported an estimated 1.4 million new cancer cases in 2022 as per International Agency for Research on Cancer (IARC) data.